◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

COSMOS Pharmaceutical Corporation (3349) Revenue 2022–2025

Name: COSMOS Pharmaceutical Corporation (3349) revenue history 2022-2025
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-08-10

COSMOS Pharmaceutical Corporation annual revenue for fiscal 2025 was JPY 1.01 trillion, an increase of 4.8% from JPY 965.0 billion in fiscal 2024. All figures are reported results from public filings — no estimates or projections.

3349 Annual Revenue

Revenue (annual)	2025-05-31	2024-05-31	2023-05-31	2022-05-31
Total Revenue	JPY 1.01T	JPY 965.0B	JPY 827.7B	JPY 755.4B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Revenue at Comparable Companies

3391 Revenue — Tsuruha Holdings Inc.
3088 Revenue — MatsukiyoCocokara & Co.
7649 Revenue — Sugi Holdings Co.,Ltd.
9989 Revenue — Sundrug Co.,Ltd.
3549 Revenue — Kusuri No Aoki Holdings Co., Ltd.
3148 Revenue — Create SD Holdings Co., Ltd.

More 3349 metrics: Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow

All 3349 financial statements → Interactive 3349 charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.